PTTG1IP (PTTG1 interacting protein) is a proto-oncogene that plays multifaceted roles in cellular processes and disease progression. The primary function of PTTG1IP involves facilitating the nuclear translocation of PTTG1 (securin), which is crucial for proper cell cycle regulation during metaphase-anaphase transition 1. PTTG1IP forms endogenous complexes with proteins like cortactin and occupies promoter regions of DNA damage response genes including BRCA1, BRCA2, RAD51, and ATM, thereby coupling cytoskeletal programs with DNA damage response control 2. The protein is transcriptionally regulated by Sp4, which increases PTTG1IP gene transcription and expression 3. In disease contexts, PTTG1IP demonstrates significant clinical relevance across multiple cancer types. It is upregulated in gastric cancer resistance to docetaxel treatment and contributes to therapy resistance through regulation of ROS production, autophagy, and apoptosis 4. In thyroid cancer, PTTG1IP orchestrates epithelial-mesenchymal transition and supports treatment tolerance by enhancing DNA damage response capabilities 2. PTTG1IP negativity in breast cancer patients predicts increased mortality risk, with prognostic significance extending up to 14 years 1. The protein also plays roles in maintaining tumor cell dormancy in lung adenocarcinoma and contributes to inflammatory responses in rheumatoid arthritis through the miR-671-5p/TLR4 axis 56.